# Eyenovia Inc. (EYEN)

Source: https://www.quantisnow.com/company/EYEN
Generated: 2026-11-09T22:49:16.369Z

- Ticker: EYEN
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2018
- Website: eyenovia.com

## About

Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print (MAP) platform technology. The company focuses on to develop clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. Its pipelines focus on the development of therapeutic indications for patients with progressive myopia and age-related near vision impairment or presbyopia indications; and microdose fixed combination ophthalmic pharmaceutical for mydriasis to address the eye exams with pupil dilation. The company's product candidates in pipeline include MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); and MydCombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; and a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine and MicroLine in China and South Korea. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is headquartered in New York, New York.

## Latest EYEN news and filings

- 2025-07-11 12:26 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Eyenovia Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-eyenovia-inc-6117608)
- 2025-07-09 20:04 UTC [SEC Form 4] [Chief Investment Officer Jung Hyunsu was granted 500,000 shares (SEC Form 4)](https://www.quantisnow.com/insight/chief-investment-officer-jung-hyunsu-was-granted-500000-shares-sec-6115455)
- 2025-07-09 20:04 UTC [SEC Form 4] [Director Jacobson Rachel was granted 5,000 shares, increasing direct ownership by 384% to 6,301 units (SEC Form 4)](https://www.quantisnow.com/insight/director-jacobson-rachel-was-granted-5000-shares-increasing-direct-ownership-6115426)
- 2025-07-09 20:03 UTC [SEC Form 4] [Chief Executive Officer Rowe Michael M was granted 6,600 shares, increasing direct ownership by 480% to 7,975 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-rowe-michael-m-was-granted-6600-shares-6115423)
- 2025-07-09 20:03 UTC [SEC Form 4] [Director Geltzeiler Michael S was granted 7,000 shares, increasing direct ownership by 690% to 8,015 units (SEC Form 4)](https://www.quantisnow.com/insight/director-geltzeiler-michael-s-was-granted-7000-shares-increasing-direct-6115421)
- 2025-07-09 20:02 UTC [SEC Form 4] [Director Strahlman Ellen R was granted 5,000 shares, increasing direct ownership by 293% to 6,706 units (SEC Form 4)](https://www.quantisnow.com/insight/director-strahlman-ellen-r-was-granted-5000-shares-increasing-direct-6115415)
- 2025-07-09 20:01 UTC [SEC Form 3] [SEC Form 3 filed by new insider Jung Hyunsu](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-jung-hyunsu-6115411)
- 2025-07-02 20:49 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by Eyenovia Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-eyenovia-inc-6109002)
- 2025-07-02 20:16 UTC [SEC Form 8-K] [Eyenovia Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/eyenovia-inc-filed-sec-form-8-k-amendments-to-articles-of-6108455)
- 2025-07-02 12:00 UTC [Eyenovia Announces Rebranding and Corporate Name Change to Hyperion DeFi, Inc.](https://www.quantisnow.com/insight/eyenovia-announces-rebranding-and-corporate-name-change-to-hyperion-defi-6107165)
- 2025-06-30 12:00 UTC [Eyenovia Adds $10 Million in HYPE to its Treasury Holdings in Preparation for Strategic Onchain Engagement](https://www.quantisnow.com/insight/eyenovia-adds-10-million-in-hype-to-its-treasury-holdings-6102900)
- 2025-06-27 21:07 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Eyenovia Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-eyenovia-inc-6102238)
- 2025-06-27 21:06 UTC [SEC Form 8-K] [Eyenovia Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/eyenovia-inc-filed-sec-form-8-k-regulation-fd-disclosure-other-6102232)
- 2025-06-25 12:30 UTC [Eyenovia Announces Co-Branded Validator with Kinetiq](https://www.quantisnow.com/insight/eyenovia-announces-co-branded-validator-with-kinetiq-6098393)
- 2025-06-24 20:05 UTC [SEC Form 8-K] [Eyenovia Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/eyenovia-inc-filed-sec-form-8-k-entry-into-a-material-6097268)
- 2025-06-23 12:30 UTC [Public Offering] [Eyenovia Announces Closing of $50 Million Private Placement, Successful Accumulation of More Than One Million HYPE Tokens, and Update on its Optejet Development Program](https://www.quantisnow.com/insight/eyenovia-announces-closing-of-50-million-private-placement-successful-accumulation-6095003)
- 2025-06-18 18:04 UTC [Chardan Expands into Digital Assets by Advising Strategic Crypto-Backed Financings](https://www.quantisnow.com/insight/chardan-expands-into-digital-assets-by-advising-strategic-crypto-backed-financings-6091580)
- 2025-06-18 12:32 UTC [Leadership Update] [Eyenovia Announces Appointment of a Strategic Advisor for Digital Asset Treasury Strategy and Amendment of Debt Agreement with Avenue Capital Group](https://www.quantisnow.com/insight/eyenovia-announces-appointment-of-a-strategic-advisor-for-digital-asset-6091241)
- 2025-06-17 18:55 UTC [Public Offering] [Eyenovia Announces $50 Million Investment to Launch a Hyperliquid (HYPE token) Cryptocurrency Treasury Reserve Strategy](https://www.quantisnow.com/insight/eyenovia-announces-50-million-investment-to-launch-a-hyperliquid-hype-6089677)
- 2025-06-05 12:00 UTC [SEC Form 8-K] [Eyenovia Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/eyenovia-inc-filed-sec-form-8-k-entry-into-a-material-6073747)
- 2025-06-04 01:18 UTC [SEC Form 4] [SEC Form 4 filed by Large owner Avenue Capital Management Ii, L.P.](https://www.quantisnow.com/insight/sec-form-4-filed-by-large-owner-avenue-capital-management-6071279)
- 2025-06-04 01:07 UTC [SEC Form 3] [New insider Avenue Capital Management Ii, L.P. claimed ownership of 30,619 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-avenue-capital-management-ii-lp-claimed-ownership-of-6071264)
- 2025-06-02 20:01 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Eyenovia Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-eyenovia-inc-6067314)
- 2025-05-19 21:30 UTC [SEC Form 8-K] [Eyenovia Inc. filed SEC Form 8-K: Results of Operations and Financial Condition](https://www.quantisnow.com/insight/eyenovia-inc-filed-sec-form-8-k-results-of-operations-and-6048617)
- 2025-05-19 21:30 UTC [Eyenovia Provides Updates on Potential Merger with Betaliq and Development of the Optejet User Filled Device (UFD), and Reports First Quarter 2025 Financial Results](https://www.quantisnow.com/insight/eyenovia-provides-updates-on-potential-merger-with-betaliq-and-development-6048612)
- 2025-05-19 21:01 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Eyenovia Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-eyenovia-inc-6048403)
- 2025-05-15 20:59 UTC [SEC Form NT 10-Q filed by Eyenovia Inc.](https://www.quantisnow.com/insight/sec-form-nt-10-q-filed-by-eyenovia-inc-6043431)
- 2025-05-02 21:20 UTC [SEC Form 8-K] [Eyenovia Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant](https://www.quantisnow.com/insight/eyenovia-inc-filed-sec-form-8-k-changes-in-registrants-certifying-6016426)
- 2025-05-02 21:15 UTC [SEC Form 8-K] [Eyenovia Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/eyenovia-inc-filed-sec-form-8-k-notice-of-delisting-or-6016386)
- 2025-04-30 20:05 UTC [SEC Form 10-K] [Amendment: SEC Form 10-K/A filed by Eyenovia Inc.](https://www.quantisnow.com/insight/amendment-sec-form-10-ka-filed-by-eyenovia-inc-6010293)
- 2025-04-29 23:58 UTC [SEC Form 4] [Amendment: Director Strahlman Ellen R was granted 3,000 shares, increasing direct ownership by 176% to 4,706 units (SEC Form 4)](https://www.quantisnow.com/insight/amendment-director-strahlman-ellen-r-was-granted-3000-shares-increasing-6008320)
- 2025-04-29 23:57 UTC [SEC Form 4] [Amendment: Director Palanki Ram was granted 3,000 shares, increasing direct ownership by 243% to 4,235 units (SEC Form 4)](https://www.quantisnow.com/insight/amendment-director-palanki-ram-was-granted-3000-shares-increasing-direct-6008319)
- 2025-04-29 23:56 UTC [SEC Form 4] [Amendment: Director Mather Charles E Iv was granted 8,000 shares, increasing direct ownership by 410% to 9,950 units (SEC Form 4)](https://www.quantisnow.com/insight/amendment-director-mather-charles-e-iv-was-granted-8000-shares-6008318)
- 2025-04-29 23:54 UTC [SEC Form 4] [Amendment: Director Jacobson Rachel was granted 3,000 shares, increasing direct ownership by 231% to 4,301 units (SEC Form 4)](https://www.quantisnow.com/insight/amendment-director-jacobson-rachel-was-granted-3000-shares-increasing-direct-6008316)
- 2025-04-29 23:52 UTC [SEC Form 4] [Amendment: Director Ianchulev Tsontcho was granted 5,000 shares, increasing direct ownership by 98% to 10,122 units (SEC Form 4)](https://www.quantisnow.com/insight/amendment-director-ianchulev-tsontcho-was-granted-5000-shares-increasing-direct-6008315)
- 2025-04-29 23:51 UTC [SEC Form 4] [Amendment: Director Geltzeiler Michael S was granted 5,000 shares, increasing direct ownership by 493% to 6,015 units (SEC Form 4)](https://www.quantisnow.com/insight/amendment-director-geltzeiler-michael-s-was-granted-5000-shares-increasing-6008314)
- 2025-04-28 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Eyenovia Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-eyenovia-inc-6003550)
- 2025-04-25 20:00 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Eyenovia Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-eyenovia-inc-6002394)
- 2025-04-24 01:37 UTC [SEC Form 4] [Director Strahlman Ellen R was granted 3,000 shares, increasing direct ownership by 176% to 4,707 units (SEC Form 4)](https://www.quantisnow.com/insight/director-strahlman-ellen-r-was-granted-3000-shares-increasing-direct-5999150)
- 2025-04-24 01:36 UTC [SEC Form 4] [Director Palanki Ram was granted 3,000 shares, increasing direct ownership by 243% to 4,236 units (SEC Form 4)](https://www.quantisnow.com/insight/director-palanki-ram-was-granted-3000-shares-increasing-direct-ownership-5999148)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/EYEN
- Earnings history: https://www.quantisnow.com/earnings/EYEN
- Dividend history: https://www.quantisnow.com/dividends/EYEN
- Insider transactions: https://www.quantisnow.com/insiders/EYEN
- Options chain: https://www.quantisnow.com/options/EYEN
- SEC 8-K filings only: https://www.quantisnow.com/company/EYEN/8-k
- RSS and alerts for EYEN: https://www.quantisnow.com/docs/rss-feeds.md